Trials / Unknown
UnknownNCT05938088
Mirogabalin for Total Hip Arthroplasty
Mirogabalin and Pain After Total Hip Arthroplasty: a Double-blind, Randomized, Placebo-controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (estimated)
- Sponsor
- Gangnam Severance Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to confirm the analgesic effect of mirogabalin in patients undergoing unilateral hip arthroplasty.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Arm I (mirogabalin group) | Take two capsules of Mirogabalin 5 mg within 30 minutes before going to the operating room. Patients take 5 mg of mirogabalin twice daily at 12-hour intervals until POD 7 days. |
| DRUG | Arm II (placebo group) | It is performed in the same way as Arm l. |
Timeline
- Start date
- 2023-07-20
- Primary completion
- 2025-06-28
- Completion
- 2025-06-28
- First posted
- 2023-07-10
- Last updated
- 2023-08-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05938088. Inclusion in this directory is not an endorsement.